CER Groupe
Olivier Vanloocke is an experienced executive in the biopharmaceutical and vaccine manufacturing industry, currently serving as CEO of CER Groupe since March 2021. Prior to this role, Olivier operated as a Senior Operations Consultant, where consultant work included establishing Curevac's Covid-19 mRNA vaccine manufacturing network and serving as interim COO for BePharbel Manufacturing. Olivier's extensive tenure at GSK Vaccines spanned 25 years, culminating in the position of Senior Director of Primary Operations with accountability for a large workforce and multi-product manufacturing units. Key achievements at GSK include leading operational strategies, implementing lean manufacturing programs, and successful capital investment projects aimed at enhancing operational efficacy and regulatory compliance. Olivier's career began as a veterinary practitioner after earning a Doctorate in Veterinary Medicine from the University of Liège.
This person is not in any teams
CER Groupe
Ideally located within the Walloon Biotech network, CER Groupe provides companies, universities, institutions and individuals with high quality services in life sciences and agriculture. The group offer stands out by providing an end-to-end pre-clinical solution in a regulated environment (ISO, GxP) helping innovative compagnies to incubate, grow and take off in Belgium and abroad. Manufacturer of innovative products, the group delivers pharmaceutical and food industry with polyclonal and monoclonal antibodies, diagnostic kits as well as reagents and colostrum. Recognised for its competencies and high quality level of services, the group contributes to the agricultural economical development supporting the Walloon Region Agriculture Policies and European CAP. Idéalement positionné au sein du réseau biotechnologique wallon, le CER Groupe fournit aux entreprises, institutions, universités et particuliers des services de qualité dans le domaine des sciences du vivant et de l’agriculture. Le groupe se différencie par son offre pré-clinique transversale, exécutée dans un cadre normé (ISO, GxP), permettant d’apporter une réponse complète dans l’accompagnement, l’incubation et la croissance des entreprises innovantes en Belgique et à l’étranger. Producteur de produits innovants, le groupe délivre au secteur pharmaceutique et alimentaire des anticorps polyclonaux et monoclonaux, des kits de diagnostic ainsi que leurs réactifs et du colostrum. Reconnu pour ses compétences et ses services de qualité au secteur agricole, le groupe contribue au développement économique du secteur en support à la Politique Agricole Wallonne et à la PAC Européenne.